Lifeforce, MD-Led Platform

Lifeforce is a health optimization company founded by Peter Diamandis, M.D. — the physician, entrepreneur, and author known for co-founding Singularity University and the X Prize — and Tony Robbins, whose platform has given the company unusual consumer reach in the wellness market. The company launched with the premise that the medical system is designed to treat disease reactively, not to optimize health proactively, and that a membership-based platform combining diagnostics, clinicians, and therapeutics could fill that gap for health-motivated individuals willing to invest in their biology. The core of the Lifeforce experience is the at-home diagnostic draw. Rather than requiring members to schedule a visit to a blood draw center, Lifeforce dispatches a licensed phlebotomist to the member's home to collect samples for a panel covering more than 50 biomarkers — spanning hormonal health (testosterone, DHEA, cortisol, thyroid), metabolic function (insulin, glucose, lipids), cardiovascular markers, inflammation, and nutrient levels. This convenience differentiator is meaningful in a market where lab logistics often create friction that causes patients to delay or skip monitoring. Results are analyzed through Lifeforce's proprietary Lifescore algorithm, which translates biomarker data into a single wellness metric calibrated against optimal — not merely "normal" — ranges. The distinction matters: standard lab reference ranges reflect population averages including unhealthy individuals, while optimal ranges are calibrated toward peak function. A clinician then conducts a 45-minute telehealth consultation to walk the member through their results, identify their top priorities, and design a personalized protocol. The Lifeforce membership unlocks access to prescription therapeutics that most primary care physicians are either unfamiliar with or unwilling to prescribe in a standard appointment context — including bioidentical hormone therapy for both men and women, peptides for body composition and recovery, and advanced nutraceuticals. Medications are priced separately from the membership, so total monthly spend varies depending on what is prescribed. At $149/month with quarterly retesting, Lifeforce sits at the premium end of the biomarker-driven membership market but below true executive health programs like Fountain Life. For men and women who want a rigorous, physician-supported longevity practice delivered without leaving home, it is one of the most complete consumer-facing offerings available. The company launched with the premise that the medical system is designed to treat disease reactively, not to optimize health proactively, and that a membership-based platform combining diagnostics, clinicians, and therapeutics could fill that gap for health-motivated individuals willing to invest in their biology. The core of the Lifeforce experience is the at-home diagnostic draw. Rather than requiring members to schedule a visit to a blood draw center, Lifeforce dispatches a licensed phlebotomist to the member's home to collect samples for a panel covering more than 50 biomarkers — spanning hormonal health (testosterone, DHEA, cortisol, thyroid), metabolic function (insulin, glucose, lipids), cardiovascular markers, inflammation, and nutrient levels. This convenience differentiator is meaningful in a market where lab logistics often create friction that causes patients to delay or skip monitoring. Results are analyzed through Lifeforce's proprietary Lifescore algorithm, which translates biomarker data into a single wellness metric calibrated against optimal — not merely "normal" — ranges. The distinction matters: standard lab reference ranges reflect population averages including unhealthy individuals, while optimal ranges are calibrated toward peak function. A clinician then conducts a 45-minute telehealth consultation to walk the member through their results, identify their top priorities, and design a personalized protocol. The Lifeforce membership unlocks access to prescription therapeutics that most primary care physicians are either unfamiliar with or unwilling to prescribe in a standard appointment context — including bioidentical hormone therapy for both men and women, peptides for body composition and recovery, and advanced nutraceuticals. Medications are priced separately from the membership, so total monthly spend varies depending on what is prescribed. At $149/month with quarterly retesting, Lifeforce sits at the premium end of the biomarker-driven membership market but below true executive health programs like Fountain Life. For men and women who want a rigorous, physician-supported longevity practice delivered without leaving home, it is one of the most complete consumer-facing offerings available.